Advanced Search

 

Study ID Status Title Patient Level Data
SUM40257 Completed A randomised, multi-centre, open-label, crossover study to evaluate patient preference for sumatriptan 50mg and 100mg, naratriptan 2.5mg, rizatriptan 10mg and zolmitriptan 2.5mg tablets in the acute treatment of migraine.
SUM40260 Completed Patient Preference for and Satisfaction With Migraine Therapy: IMITREX® Tablets Versus Pre-Study Non-Triptan Therapy.Imitrex is a registered trademark of GlaxoSmithKline.
SUM40265 Completed A prospective multicentre study investigating the association between disability (as measured by the headache impact test, HIT-6) and IHS migraine classification (as determined by expert panel diary review) and to observe any changes in HIT-6 score following treatment with oral sumatriptan 50mg.
SUM40272 Completed An open-label, randomized, cross-over study to investigate the potential pharmacokinetic interaction of sumatriptan and clarithromycin when co-administered to healthy volunteers.
SUM40273 Completed An open-label study to investigate the potential pharmacokinetic interaction of sumatriptan and an oral contraceptive when co-administered to healthy volunteers.
SUM40274 Completed Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Evaluation of Sumatriptan Tablets 50 mg and 100 mg Versus Placebo During a Migraine Headache at the First Sign of Pain.
SUM40275 Completed Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Evaluation of Sumatriptan Tablets 50 mg and 100 mg Versus Placebo During a Migraine Headache at the First Sign of Pain.
SUM40276 Completed Final study report for protocol SUM40276 entitled “An open-label, long-term observational study ofthe safety and tolerability of sumatriptan nasal spray in the treatment of migraine in adolescents.”
SUM40282 Completed A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack Study Listed on ClinicalStudyDataRequest.com
SUM40285 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack Study Listed on ClinicalStudyDataRequest.com
SUM40286 Completed A randomized, double-blind, placebo-controlled, parallel-group, single-attack study of sumatriptan 6 mg injection in the treatment of moderate-to-severe migraine present upon awakening. Study Listed on ClinicalStudyDataRequest.com
SUM40287 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study of Sumatriptan 6 mg Injection In the Treatment of Moderate-to-Severe Migraine Present Upon Awakening. Study Listed on ClinicalStudyDataRequest.com
SUM40291 Completed A randomized, double-blind, placebo-controlled, parallel-group, single-attack evaluation of sumatriptan 50mg and 100mg versus placebo during a migraine headache at the first sign of pain.
SUM40292 Completed A randomised, multi-centre, single-blind, cross-over study to investigate the efficacy and safety of sumatriptan 25mg suppositories compared to naproxen 500mg suppositories in the acute, early treatment of migraine in patients suffering from nausea and/or vomiting during their attacks.
SUM40294 Completed Identification of Migraine Headache Among Self-Described and/or Physician Diagnosed Sinus Headache Sufferers and Treatment with IMITREX† 50mg Tablets Study Listed on ClinicalStudyDataRequest.com
SUM40298 Completed A randomized, double-blind, placebo-controlled, single-attack, parallel-group evaluation of the efficacy of sumatriptan 50mg tablets versus placebo in the treatment of self-described and/or physician-diagnosed sinus headaches that meet International Headache Society (IHS) criteria for migraine headache. Study Listed on ClinicalStudyDataRequest.com
SUM40299 Completed A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and tolerability of oral sumatriptan 25mg, 50mg, and 100mg tablets for a single moderate or severe headache in adults diagnosed with migrainous disorder International Headache Society (IHS) 1.7. Study Listed on ClinicalStudyDataRequest.com
SUM40301 Completed An open-label evaluation of patient satisfaction with IMITREX (sumatriptan succinate) tablets, 100mg, administered at the first sign of pain for up to three migraines in patients who are not satisfied with their current triptan therapy. Study Listed on ClinicalStudyDataRequest.com
SUM40304 Completed A randomised, double-blind, placebo controlled, cross-over clinical trial to investigate the relation of migraine recurrence and anxiety-depressive symptoms in patients treated with Sumatriptan.
SUM40308 Completed A Danish, randomised, multicentre, comparative, parallel-group study of the effect of sumatriptan 50mg versus placebo in migraine patients with 6 to 11 attacks per year, taken during the mild phase of a migraine attack.
SUM40310 Completed A randomised, open, parallel-group study comparing intake of sumatriptan 100mg tablets at the first signs of migraine pain versus intake at moderate to severe headache during an acute migraine attack.
SUM40311 Completed A randomized, double-blind, placebo-controlled, single-attack, parallel-group evaluation of the efficacy of sumatriptan 100mg tablets versus placebo in the treatment of self-described and/or physician-diagnosed sinus headaches that meet International Headache Society (IHS) criteria for migraine ...
SUM40312 Completed A Randomized, Double-Blind, Placebo-Controlled, Single-Attack, Parallel-Group Evaluation of the Efficacy of Sumatriptan 100mg Tablets versus Placebo in the Treatment of Subjects who Affirm Tension, Tension-Type or Stress Headaches and who meet International Headache Society (IHS) Criteria for Migraine. Study Listed on ClinicalStudyDataRequest.com
SUMA2002 Completed A randomized, double-blind, placebo-controlled study of the safety and efficacy of 25mg, 50mg and 100mg oral sumatriptan in adolescent migraine subjects.
SUMA3005 Completed A double-blind. placebo-controlled, parallel group study to evaluate three dose levels (5mg, 10mg and 20mg) of sumatriptan nasal spray in the acute treatment of a single migraine attack in adolescent migraineurs (12-17 years of age).

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.